GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 4101 - 4150 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
8FXC 8FXC SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
8FXB Q9BYF1 SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
8FXB P0DTC2 SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
8FXB 8FXB SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
8FWW P42260 Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel
8FWV P42260 Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel
8FWU P42260 Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX
8FWT P42260 Structure of the amino terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX
8FWS P42260 Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344
8FWR P42260 Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344
8FWQ P42260 Structure of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344
8FUX A0A0H2Z2W8 KpsC D160C ternary complex
8FUW A0A0H2Z2W8 KpsC D160N Kdo adduct
8FU9 P0DTC2 Structure of Covid Spike variant deltaN25 with one erect RBD
8FU8 P0DTC2 Structure of Covid Spike variant deltaN135 with one erect RBD
8FU7 P0DTC2 Structure of Covid Spike variant deltaN135 in fully closed form
8FT4 O67854 Multicrystal structure of Na+, leucine-bound LeuT determined at 5 keV
8FSZ E9QLC0 Full-length mouse 5-HT3A receptor in complex with ALB148471, open-like
8FSP E9QLC0 Full-length mouse 5-HT3A receptor in complex with SMP100, open-like
8FSJ 8FSJ Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSJ A0A2P0NE34 Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSJ 8FSJ Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSJ A0A2P0NE34 Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSJ A0A2P0NE15 Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSJ A0A2P0NE15 Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520
8FSB E9QLC0 Full-length mouse 5-HT3A receptor in complex with serotonin, open-like
8FRZ E9QLC0 Full-length mouse 5-HT3A receptor in complex with serotonin, pre-activated
8FRX E9QLC0 Full-length mouse 5-HT3A receptor in complex with SMP100, pre-activated
8FRW E9QLC0 Full-length mouse 5-HT3A receptor in complex with ALB148471, pre-activated
8FRN Q6FC66 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin
8FRN Q6FFD7 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin
8FRN Q6FFD6 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and Zosurabalpin
8FRL Q6FC66 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide
8FRL Q6FFD7 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide
8FRL Q6FFD6 Acinetobacter baylyi LptB2FG bound to lipopolysaccharide and a macrocyclic peptide
8FRG Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.43
8FRD Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.25
8FRC Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 4.91
8FRB Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.25
8FRA Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with diacetylchitobiose at pH 5.60
8FR9 Q91XA9 Mouse acidic mammalian chitinase, catalytic domain in complex with N,N'-diacetylchitobiose at pH 5.08
8FR7 Q6Q1S2 A hinge glycan regulates spike bending and impacts coronavirus infectivity
8FR6 Q2N0S7 Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8FR6 Q2N0S6 Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8FR6 8FR6 Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8FQ9 P30878 Crystal structure of a ligand-bound cation-site mutant D55C of a melibiose transporter
8FOI P62812 Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
8FOI P63137 Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
8FOI P22723 Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
8FOI 8FOI Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024